| Company Name | KAKEN PHARMACEUTICAL CO., LTD. |
|---|---|
| Representative | Hiroyuki Horiuchi, President and Representative Director |
| Incorporated | March 1, 1948 |
| Head Office | 28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo 113-8650, Japan
|
| Number of shares | Authorized 193,000,000 Issued 45,939,730 (As of March 31, 2023) |
| Number of Shareholders | 12,890 (As of March 31, 2023) |
| Paid-in Capital | ¥23,853 million (As of March 31, 2023) |
| Listing | Tokyo Stock Exchange |
| Securities Code | 4521 |
| Business | Manufacturing and marketing of pharmaceuticals, medical devices, agrochemicals, feed additives and drugs for animals as well as real estate leasing |
| Number of Employees | 1,130 (Consolidated; As of March 31, 2023) |